Vertex Pharmaceuticals Inc. buy Redburn Atlantic
Start price
27.06.24
/
50%
€445.55
Target price
27.06.25
€508.32
Performance (%)
-15.44%
End price
28.06.25
€376.75
Summary
This prediction ended on 28.06.25 with a price of €376.75. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.44%. Redburn_Atlantic has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.509% | -1.509% | -12.791% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Redburn_Atlantic for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Redburn_Atlantic gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Redburn Atlantic. They set a "buy" rating and a $545.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat